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Abstract
Background: Depressive and anxiety disorders often go unrecognized in distressed primary care patients, despite the overtly
psychosocial nature of their demand for help. This is especially problematic in more severe disorders needing specific treatment
(e.g. antidepressant pharmacotherapy or specialized cognitive behavioural therapy). The use of a screening tool to detect (more
severe) depressive and anxiety disorders may be useful not to overlook such disorders. We examined the accuracy with which
the Four-Dimensional Symptom Questionnaire (4DSQ) and the Hospital Anxiety and Depression Scale (HADS) are able to
detect (more severe) depressive and anxiety disorders in distressed patients, and which cut-off points should be used.
Methods: Seventy general practitioners (GPs) included 295 patients on sick leave due to psychological problems. They excluded
patients with recognized depressive or anxiety disorders. Patients completed the 4DSQ and HADS. Standardized diagnoses of
DSM-IV defined depressive and anxiety disorders were established with the Composite International Diagnostic Interview
(CIDI). Receiver Operating Characteristic (ROC) analyses were performed to obtain sensitivity and specificity values for a range
of scores, and area under the curve (AUC) values as a measure of diagnostic accuracy.
Results: With respect to the detection of any depressive or anxiety disorder (180 patients, 61%), the 4DSQ and HADS scales
yielded comparable results with AUC values between 0.745 and 0.815. Also with respect to the detection of moderate or severe
depressive disorder, the 4DSQ and HADS depression scales performed comparably (AUC 0.780 and 0.739, p 0.165). With
respect to the detection of panic disorder, agoraphobia and social phobia, the 4DSQ anxiety scale performed significantly better
than the HADS anxiety scale (AUC 0.852 versus 0.757, p 0.001). The recommended cut-off points of both HADS scales
appeared to be too low while those of the 4DSQ anxiety scale appeared to be too high.
Conclusion: In general practice patients on sick leave because of psychological problems, the 4DSQ and the HADS are equally
able to detect depressive and anxiety disorders. However, for the detection of cases severe enough to warrant specific
treatment, the 4DSQ may have some advantages over the HADS, specifically for the detection of panic disorder, agoraphobia
and social phobia.
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Background
Depressive and anxiety disorders are prevalent in primary
care patients, although these disorders are often not recog-
nized as such by the general practitioner (GP) [1-3]. One
explanation for non-recognition of psychiatric disorders
concerns the time constraints in general practice, and the
competing demands put upon the GP [4]. A special situa-
tion occurs in patients with an overt psychosocial presen-
tation. These distressed patients present with
psychological complaints, such as nervousness or feeling
depressed, or psychosocial problems, such as occupa-
tional or marital problems, which are readily available for
discussion with the GP [5]. Because these complaints and
problems often arise in the context of 'life stress', the dis-
cussion usually remains exclusively focused on psychoso-
cial problems, not on complaints and symptoms that
might indicate a specific psychiatric disorder. In order to
diagnose such disorders, GPs need to make a clinical
assessment of certain symptoms. However, it is not always
easy for the GP to change the subject of the discussion
away from the (presumed) causes of the symptoms,
towards an assessment of the symptoms themselves.
Therefore, whereas GPs are fully aware of the presence of
psychological problems, they may fail to establish specific
psychiatric diagnoses of depressive and anxiety disorders
in many cases where such diagnoses are justified [6]. This
is especially problematic in more severe psychiatric disor-
ders since these often require specific treatment. The use
of questionnaires can be a useful strategy to detect (more
severe) depressive and anxiety disorders in patients with
relatively high risks, i.e. in patients presenting with dis-
tress in general practice [7].
In this study we examined and compared the diagnostic
accuracy of two questionnaires, the Four-Dimensional
Symptom Questionnaire (4DSQ) and the Hospital Anxi-
ety and Depression Scale (HADS), with respect to the
detection of DSM-IV defined depressive and anxiety disor-
ders in a sample of distressed patients in primary care with
and without such disorders. In distressed patients we do
not need questionnaires to detect mild depressive or anx-
iety disorders (let alone depressive or anxiety symptoms)
since these patients often need no other interventions
than non-specific counselling or problem-solving focused
on how to cope with the stress in the patients' lives [8]. On
the other hand, it is specifically important to identify
patients with more severe disorders who may be in need
of specific treatment (e.g. antidepressant pharmacother-
apy or specialized cognitive behavioural therapy). There-
fore, we did not only look at how well the 4DSQ and the
HADS detected any DSM-IV defined depressive and anxi-
ety disorders but we also analyzed, more specifically, how
well these questionnaires detected moderate and severe
major depressive disorders, panic disorder, agoraphobia
and social phobia.
Methods
Patients and procedure
We analyzed cross-sectionally baseline data collected for a
randomized controlled trial concerning an activating
social work intervention for distressed patients in general
practice [9]. Patients were included in the study if they
were aged 18–60, had a 'nervous breakdown' according to
the GP, were employed, and had been on sick leave for no
longer than three months. Dutch GPs use the diagnostic
label 'nervous breakdown' (or 'overstressed', in Dutch
'overspanning') for a syndrome that is associated with too
much stress to the extent that the patient cannot cope any-
more [10,11]. This condition is characterized by psycho-
logical distress, failure to cope, and social dysfunctioning
(i.e. sick leave in employed people) [12]. The GPs were
instructed not to include patients with obvious depressive
and anxiety disorders (i.e. patients in whom they had clin-
ically diagnosed such disorders). Adequate command of
the Dutch language, and no current psychological treat-
ment were additional inclusion criteria. Between August
2001 and July 2003, 70 GPs in the city of Almere, the
Netherlands, assessed and referred 370 patients to the
study centre. The patients were contacted by telephone,
information about the study was given and inclusion cri-
teria were checked. Thirty patients were unwilling to par-
ticipate, and a further 33 patients did not meet the
inclusion criteria. With the remaining patients an
appointment was made for a baseline interview in their
homes and they were sent written information and base-
line questionnaires by post. The home visit took place on
average 5.7 days after the initial telephone contact. After
the patients had been fully informed about the study,
written informed consent was obtained. The participating
patients (n = 307) were then interviewed, and subse-
quently their questionnaires were checked for missing val-
ues by the interviewer. Unfortunately, the date at which
the questionnaires were completed was not recorded.
Therefore, the exact time interval between the question-
naires and the interviews is unknown, but we estimate it
to be on average between 2 and 5 days. Because 12
patients failed to complete the questionnaires, the sample
for the present study comprised 295 patients. Prior to the
start of the study, approval was obtained from the ethical
committee of the Netherlands Institute of Mental Health
and Addiction.
Measurements
The interview comprised the mood and anxiety disorder
sections of the Composite International Diagnostic Inter-
view (CIDI), a standardized diagnostic interview, devel-
oped to be applied by trained lay interviewers, resulting in
psychiatric diagnoses according to DSM-IV and ICD-10
criteria [13]. The specific phobia section was omitted
because these problems are (if not accompanied by other
mental disorders) associated with relatively little disabil-BMC Family Practice 2009, 10:58 http://www.biomedcentral.com/1471-2296/10/58
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ity and impairment [14,15] and, therefore, isolated (non-
comorbid) specific phobia appears to be of relatively little
importance in patients with a 'nervous breakdown'. The
obsessive-compulsive disorder section was omitted
because of the low prevalence of this disorder [14,16].
Accordingly, the present study used the following current
DSM-IV [17] diagnoses: major depressive disorder, dys-
thymia, bipolar disorder, generalized anxiety disorder,
panic disorder with and without agoraphobia, agorapho-
bia without panic disorder, and social phobia. The CIDI
was administered by five interviewers who received a
training course at the Dutch WHO-CIDI Training and Ref-
erence Centre at Amsterdam, after which they were certi-
fied to deliver the fully structured CIDI interview. They
used a computer-assisted version in which the questions
were presented according to diagnostic algorithms and
responses were entered directly into the computer. None
of the interviewers had any particular expertise in psychol-
ogy or psychiatry. The interviewers remained ignorant of
the CIDI-diagnoses as such.
The questionnaires encompassed the Four-Dimensional
Symptom Questionnaire (4DSQ) and the Hospital Anxi-
ety and Depression Scale (HADS). The 4DSQ is a 50-item
self-rating questionnaire measuring 'distress', 'depres-
sion', 'anxiety' and 'somatization' [18]. The 4DSQ assesses
psychological and psychosomatic symptoms experienced
during the past seven days. The distress scale (16 items,
score range 0–32) measures symptoms of general psycho-
logical distress, which is conceptualized as the most gen-
eral, most basic expression of human psychological
suffering [18,19]. The depression scale (6 items, score
range 0–12) measures severe anhedonia and depressive
cognitions (including suicidal ideation), symptoms con-
sidered to be characteristic of depressive disorder [20,21].
The anxiety scale (12 items, score range 0–24) measures
irrational fears, panic and avoidance, characteristic fea-
tures of most anxiety disorders [17]. The somatization
scale (16 items, score range 0–32) measures a range of
'psychosomatic' symptoms, characteristic of bodily dis-
tress and somatoform disorders [22]. For all 4DSQ scales,
higher scores represent higher symptom levels. In this
study, we examined the 4DSQ distress scale for its ability
to detect any depressive or anxiety disorder, and the 4DSQ
depression and anxiety scales for their abilities to detect
depressive and anxiety disorders. The 4DSQ depression
and anxiety scales are supposed to detect depressive and
anxiety disorders severe enough to consider specific treat-
ment. For the 4DSQ scales two cut-off points are recom-
mended, dividing the scales into low, moderate and high
scores (Table 1). High scores indicate a relatively high
probability of caseness, prompting an immediate clinical
diagnosis. On the other hand, low scores indicate the
probable absence of a clinically relevant disorder. Moder-
ate scores indicate a relatively low probability of caseness,
warranting follow-up and reassessment after a few weeks
[7].
The HADS is a 14-item self-rating questionnaire measur-
ing 'depression' and 'anxiety' [23-26]. Like the 4DSQ, the
HADS uses seven days as reference period. The depression
scale (7 items, score range 0–21) measures mostly anhe-
donia, a phenomenon considered to be the central char-
acteristic of major depressive disorder [21]. The anxiety
scale (7 items, score range 0–21) measures mostly symp-
toms of generalized anxiety disorder [27]. For both HADS
scales higher scores represent higher symptom levels. The
depression and anxiety scales are intended to detect
depressive and anxiety disorders in general medical set-
tings. The depression scale is specifically intended to select
those depressed patients which may be helped by the pre-
scription of an antidepressant drug [21]. Like the 4DSQ,
the HADS scales employ two cut-off points, one for the
detection of 'possible' and one for the detection of 'prob-
able' depressive or anxiety disorder (Table 1). Because the
HADS total score is sometimes recommended as a meas-
ure of general psychological distress [28,29], we examined
the total score for its ability to detect any depressive or
anxiety disorder.
Table 1: Recommended cut-off points for the 4DSQ and HADS depression and anxiety scales*
Instrument Scale Lower cut-off point Higher cut-off point
4DSQ depression ≥3 ≥6
anxiety ≥8 ≥13
HADS depression ≥8 ≥11
anxiety ≥8 ≥11
* Scores below the lower cut-off point indicate the probable absence of a disorder, scores between the lower and higher cut-off points indicate the 
possible existence of a disorder, and scores exceeding the higher cut-off point indicate the probable existence of a disorder.
4DSQ = Four-Dimensional Symptom Questionnaire
HADS = Hospital Anxiety and Depression ScaleBMC Family Practice 2009, 10:58 http://www.biomedcentral.com/1471-2296/10/58
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There is a noteworthy difference in item content between
the 4DSQ and the HADS. Unlike the 4DSQ, the HADS
contains six positively worded items, of which five belong
to the depression scale (e.g. 'I can laugh and see the funny
side of things'; 'I feel cheerful'). These five depression
items are assumed to measure anhedonia (i.e. loss of the
ability to enjoy ordinary things in life) if the scores are
reversed. In contrast, the 4DSQ depression scale heavily
rests on depressive cognitions, including suicidal ideation
(e.g. 'did you feel that everything is meaningless?'; 'did
you ever think "If only I was dead"?'). At first glance, the
4DSQ depression scale seems to tap more severe depres-
sive symptoms than the HADS depression scale. Regard-
ing anxiety, unlike the HADS anxiety scale, the 4DSQ
anxiety scale contains items on phobic fears and avoid-
ance behaviour (e.g. 'were you afraid to travel on busses,
trains or trams?'; 'were you afraid of becoming embar-
rassed when with other people?'; 'did you have to avoid
certain places because they frightened you?'). In contrast,
the HADS anxiety scale contains a few items of which the
equivalents are included in the 4DSQ distress scale (e.g.
'feeling tense', 'worrying', 'feeling restless'). Again, at first
glance, the 4DSQ anxiety scale seems to tap more severe
symptoms than the HADS anxiety scale.
The interviewers collected the questionnaires after the
CIDI-interview and checked the questionnaires for miss-
ing values. They did not have the knowledge, means or
time to calculate scale scores. The questionnaire scores
were later entered into a database by research assistants
who were ignorant of the CIDI diagnoses.
Analysis
First, we calculated Cronbach's α values as a measure of
internal consistency and an estimate of reliability, and
mean 4DSQ and HADS scores for the various diagnostic
categories.
Second, we performed Receiver Operating Characteristic
(ROC) analyses and estimated area under the curve
(AUC) values as a measure of diagnostic accuracy. The
ROC curve is a graphical representation of the sensitivity
and 1-specificity values of all possible cut-off values of a
continuous diagnostic variable [30]. The AUC value repre-
sents the probability that a randomly chosen case has a
higher score than a randomly chosen non-case [31]. Dif-
ferences between AUC values were tested using the
method outlines by Hanley and McNeil [32].
Third, we calculated sensitivity, specificity, positive pre-
dictive values (PPV) and negative predictive values (NPV)
for a range of relevant cut-off points for each scale. All
analyses were performed with SPSS 14.0.
Results
Description of the sample
The sample consisted of 178 women and 117 men with a
mean age of 39.5 years (SD 9.2). Dysthymia was diag-
nosed only in seven patients of whom six also fulfilled cri-
teria for major depressive disorder. Bipolar disorder was
diagnosed only in five patients who all had a 'mild manic
episode'. Because of the small numbers, we decided not to
include dysthymia and bipolar disorder in the further
analyses (but we did not exclude the patients). Most
patients with a major depressive disorder had a single epi-
sode; only 11% were diagnosed as having a recurrent dis-
order. Table 2 provides details about the distribution of
the CIDI/DSM-IV diagnoses, as well as the internal con-
sistency of the questionnaire scales, and the mean scores
of the scales per diagnostic category. Not surprisingly,
patients with the diagnosis of severe major depression
had the highest scores on the 4DSQ depression and HADS
depression scales. Patients with panic disorder with agora-
phobia had the highest scores on the 4DSQ anxiety scale,
while patients with panic disorder without agoraphobia
had the highest scores on the HADS anxiety scale. Further-
more, it is shown that patients with any anxiety disorder
scored about the same as patients with major depression
on both depression scales, but they scored higher than
depressed patients on both anxiety scales. These observa-
tions can partly be attributed to overlap of the diagnostic
categories (i.e. comorbidity). Of those patients with a
depressive disorder diagnosis 45% had one or more
comorbid anxiety disorder diagnoses. Of those patients
with an anxiety disorder diagnosis 66% had a comorbid
depressive disorder diagnosis.
ROC analyses
Table 3 presents the results of the ROC analyses. For four
of the five comparisons there was no statistically signifi-
cant difference between the 4DSQ and HADS scales. Only
with respect to the ability to detect panic disorder, agora-
phobia and social phobia, the 4DSQ anxiety scale per-
formed significantly better than the HADS anxiety scale.
Sensitivity, specificity, PPV and NPV
Table 4 shows the diagnostic performance of the 4DSQ
distress score and the HADS total score with respect to the
detection of any depressive or anxiety disorder. The 'opti-
mal' cut-off point of ≥ 24 on the 4DSQ distress scale,
where there is a balance between sensitivity and specifi-
city, is found in the upper third of the scale. This indicates
that severe distress is a hallmark of any CIDI/DSM-IV
depressive or anxiety disorder. A lower cut-off point of
≥20 with a relatively high sensitivity of 0.90 can be used
to exclude any depressive or anxiety disorder. The optimal
cut-off point on the HADS total scale was ≥22 with a sen-
sitivity of 0.76 and a specificity of 0.75. A lower cut-off
point of ≥20 with a sensitivity of 0.86 can be used toBMC Family Practice 2009, 10:58 http://www.biomedcentral.com/1471-2296/10/58
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exclude disorders (NPV 0.74), while a higher cut-off point
of ≥25 with a specificity of 0.85 can be used to include dis-
orders (PPV 0.85).
The diagnostic performance of the 4DSQ and HADS
depression scales are shown in Table 5 for any major
depressive disorder and Table 6 for moderate or severe
major depressive disorder. The optimal 4DSQ depression
cut-off point for any major depressive disorder was ≥4
while for moderate or severe major depressive disorder
this cut-off point was ≥5. Lower cut-off points with sensi-
tivity values of at least 0.85 to exclude caseness were ≥2 for
any and ≥3 for moderate or severe major depressive disor-
der. A higher cut-off point with a specificity value of at
least 0.85 to include caseness was ≥7 for both severity lev-
els. The optimal HADS depression cut-off point for any
major depressive disorder was ≥11 while for moderate to
severe major depressive disorder this cut-off point was
≥12. Lower cut-off points with sensitivity values of at least
0.85 to exclude caseness were ≥9 for any and ≥10 for mod-
erate or severe major depressive disorder. Higher cut-off
points with specificity values of at least 0.85 to include
caseness were ≥14 and ≥15.
The diagnostic performance of the 4DSQ and HADS anx-
iety scales are shown in Table 7 for any anxiety disorder
and Table 8 for panic disorder, agoraphobia and social
phobia. The optimal 4DSQ anxiety cut-off point for any
anxiety disorder was ≥6 while for panic disorder, agora-
phobia and social phobia the optimal cut-off point was
≥8. Lower cut-off points with sensitivity values of at least
0.85 to exclude caseness were ≥4 for any anxiety disorder
and ≥6 for panic disorder, agoraphobia and social phobia.
Higher cut-off points with specificity values of at least
0.85 to include caseness were ≥9 and ≥10. The optimal
HADS anxiety cut-off point for any anxiety disorder as
well as for panic disorder, agoraphobia and social phobia
was ≥13. Lower cut-off points with sensitivity values of at
least 0.85 to exclude caseness were ≥10 for any anxiety dis-
order and ≥11 for panic disorder, agoraphobia and social
Table 2: Distribution of CIDI/DSM-IV diagnoses, internal consistency of the scales (Cronbach's α), and mean scores (and standard 
deviations) of the scales per diagnostic category (n = 295)
questionnaire scales
Diagnoses number of patients (%) 4DSQ distress
(α 0.90)
4DSQ depression
(α 0.86)
4DSQ anxiety
(α 0.86)
HADS depression
(α 0.83)
HADS anxiety
(α 0.78)
Major depression 146 (49) 26.2 (4.9) 5.3 (3.3) 7.6 (5.5) 12.7 (3.4) 13.0 (3.7)
- mild 68 (23) 24.7 (5.2) 4.0 (2.7) 5.4 (4.7) 12.0 (3.3) 11.3 (3.4)
- moderate 36 (12) 26.4 (4.7) 5.3 (3.3) 8.7 (5.5) 12.5 (3.6) 13.7 (3.0)
- severe 42 (14) 28.4 (3.4) 7.5 (3.2) 10.2 (5.4) 14.1 (3.1) 15.0 (3.4)
Anxiety disorder 99 (34) 26.6 (5.2) 5.6 (3.4) 9.5 (5.5) 12.5 (3.4) 14.0 (3.2)
- generalized anxiety 
disorder
61 (21) 26.7 (4.9) 5.7 (3.3) 8.3 (5.4) 12.3 (3.0) 13.9 (3.1)
- panic disorder w/o
agoraphobia
12 (4) 27.5 (4.5) 6.8 (3.8) 10.3 (3.5) 12.0 (3.8) 15.7 (2.7)
- panic disorder w/
agoraphobia
11 (4) 24.7 (5.8) 5.5 (3.4) 13.8 (4.7) 12.8 (3.9) 14.2 (3.9)
- agoraphobia w/o
panic disorder
10 (3) 25.4 (8.2) 4.1 (3.2) 11.4 (7.6) 13.8 (4.6) 13.8 (3.9)
- social phobia 32 (11) 28.4 (3.6) 6.1 (3.1) 12.4 (5.5) 13.4 (3.8) 14.8 (3.0)
No depressive or anxiety 
disorder
115 (39) 18.3 (7.4) 2.2 (2.8) 3.3 (4.0) 8.1 (4.2) 9.4 (3.7)
4DSQ = Four-Dimensional Symptom Questionnaire
HADS = Hospital Anxiety and Depression Scale
w/= with, w/o = withoutBMC Family Practice 2009, 10:58 http://www.biomedcentral.com/1471-2296/10/58
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phobia. A higher cut-off point with a specificity value of at
least 0.85 to include caseness was ≥16 for both severity
levels of anxiety disorders.
Discussion
Main findings
We examined and compared the abilities of the 4DSQ and
the HADS to detect CIDI/DSM-IV defined depressive and
anxiety disorders in distressed patients in primary care.
Regarding any major depressive or any anxiety disorder,
we found that the 4DSQ and the HADS depression and
anxiety scales yielded comparable and satisfactory results
with AUC values well above 0.70. Moreover, the 4DSQ
distress scale turned out to be as effective as the HADS
total score in detecting any depressive or anxiety disorder,
which is in agreement with the conceptualization of dis-
tress as the most basic expression of human psychological
suffering. However, in distressed patients, it is specifically
important to identify the more severe disorders as these
patients may be in need for specific treatment. Therefore,
we looked at how well the 4DSQ and the HADS detected
moderate and severe major depressive disorder and panic
disorder, agoraphobia and social phobia. As it turned out,
the 4DSQ anxiety scale performed significantly better
than the HADS anxiety scale while the 4DSQ depression
scale performed a little bit better than the HADS depres-
sion scale but the difference was statistically not signifi-
cant. Given the content difference between the 4DSQ and
HADS scales, and the assumption that the 4DSQ items
refer to more severe symptoms than the HADS items,
these findings are not particularly surprising.
Furthermore, the cut-off points that we established for the
4DSQ depression scale compared reasonably well with
the recommended cut-off points of ≥3 en ≥6. However,
the cut-off points that we established for the 4DSQ anxi-
ety scale appeared to be substantially lower than the rec-
ommended cut-off points of ≥8 en ≥13, and, therefore, the
cut-off points of the 4DSQ anxiety scale may need down-
ward revision. In contrast, the cut-off points that we estab-
lished for the HADS depression and anxiety scales proved
to be substantially higher than the recommended cut-off
points of both HADS scales. Therefore, the HADS cut-off
points may need upward revision, perhaps to ≥9 and ≥14
for depression, and ≥10 and ≥16 for anxiety.
Comparison with other studies
The present 4DSQ results can be compared with the only
previous 4DSQ validation study published [18] in which
the performance of the depression scale was studied in
distressed primary care patients. This yielded an AUC
value of 0.83 and an optimal cut-off point of ≥6. In the
present study we found slightly lower AUC values and
lower optimal cut-off points, which is probably due to a
Table 3: Results of the Receiver Operating Characteristic (ROC) analyses of the 4DSQ and HADS scales with respect to detecting 
CIDI/DSM-IV depressive and anxiety disorders
Diagnostic categories/levels 4DSQ scale HADS scale Z/p
Any depressive/anxiety disorder distress total score
AUC 0.792
se 0.027
AUC 0.815
se 0.027
Z 0.525
p 0.596
Major depressive disorder depression depression
- any major depressive disorder AUC 0.745
se 0.029
AUC 0.762
se 0.028
Z 0.574
p 0.569
- moderate-severe major depressive disorder AUC 0.780
se 0.029
AUC 0.739
se 0.030
Z 1.389
p 0.165
Anxiety disorder anxiety anxiety
- any anxiety disorder AUC 0.792
se 0.028
AUC 0.757
se 0.028
Z 1.333
p 0.184
- panic disorder/agoraphobia/social phobia AUC 0.852
se 0.024
AUC 0.757
se 0.032
Z 3.294
p 0.001
4DSQ = Four-Dimensional Symptom Questionnaire
HADS = Hospital Anxiety and Depression Scale
AUC = area under the ROC curve
se = standard error
Z = standard Normal deviateBMC Family Practice 2009, 10:58 http://www.biomedcentral.com/1471-2296/10/58
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more severe case mix and a different reference standard,
the Short Depression Interview [33] in the former study.
The performance of the anxiety scale was studied in anx-
ious primary care patients yielding an AUC value of 0.66
and an optimal cut-off point of ≥10. In the present study
we found significantly higher AUC values and lower opti-
mal cut-off points, which is very likely related to an
extremely severe case mix (87% of the patients had one or
more DSM-IV anxiety disorders), little contrast between
the groups, and a different reference standard, the Struc-
tured Clinical Interview for DSM-IV (SCID) [34] in the
former study.
Our results regarding the HADS can be compared with
four primary care studies [35-38]. All studies used samples
of consecutive (i.e. unselected) patients. The study of Lam
et al. [35] was conducted in older patients (≥60 years).
Olssøn et al. [37] used self-report measures as reference
standards; the other studies used (standardized) psychiat-
ric interviews. Optimal cut-off points for the HADS
depression scale were reported to vary between ≥4 and ≥7,
and for the HADS anxiety scale between ≥3 and ≥9. In the
present study we found significantly higher optimal cut-
off points: ≥11 for any depressive disorder and ≥ 13 for
any anxiety disorder. These differences may be explained
by differences in study populations (case mix) [39,40],
reference standards and language versions of the HADS. A
study population, like consecutive primary care patients,
that includes a large proportion of healthy individuals,
causes the optimal cut-off point to shift downwards.
However, screening unselected people is far less efficient
than screening high risk groups such as patients present-
ing with psychological symptoms or reasons for encoun-
ter.
Table 4: Diagnostic performance of the 4DSQ distress scale and 
the HADS total score with respect to detecting any depressive 
or anxiety disorder (prevalence 61%)*
4DSQ distress sensitivity specificity PPV NPV
≥16 0.95 0.37 0.70 0.83
≥17 0.94 0.43 0.72 0.82
≥18 0.93 0.47 0.73 0.81
≥19 0.91 0.55 0.76 0.79
≥20 0.90 0.56 0.76 0.78
≥21 0.84 0.57 0.76 0.70
≥22 0.77 0.67 0.78 0.65
≥23 0.75 0.67 0.78 0.63
≥24 0.71 0.73 0.80 0.61
≥25 0.65 0.77 0.82 0.59
≥26 0.61 0.80 0.83 0.57
≥27 0.56 0.84 0.85 0.55
≥28 0.48 0.85 0.83 0.51
≥29 0.36 0.90 0.85 0.48
≥30 0.28 0.94 0.88 0.46
≥31 0.19 0.97 0.90 0.43
HADS total score
≥16 0.96 0.41 0.72 0.86
≥17 0.93 0.46 0.73 0.80
≥18 0.92 0.50 0.74 0.80
≥19 0.89 0.59 0.77 0.78
≥20 0.86 0.64 0.79 0.74
≥21 0.82 0.68 0.80 0.71
≥22 0.76 0.75 0.82 0.66
≥23 0.71 0.80 0.85 0.64
≥24 0.63 0.84 0.86 0.59
≥25 0.56 0.85 0.85 0.55
≥26 0.46 0.88 0.85 0.51
≥27 0.39 0.89 0.84 0.48
≥28 0.32 0.91 0.85 0.46
≥29 0.27 0.92 0.84 0.45
≥30 0.21 0.95 0.86 0.43
* For each scale three cut-off points are highlighted in bold type: the 
optimal cut-off point with the best balance between sensitivity and 
specificity, the best lower cut-off point with a sensitivity ≥0.85, and 
the best higher cut-off point with a specificity ≥0.85
4DSQ = Four-Dimensional Symptom Questionnaire
HADS = Hospital Anxiety and Depression Scale
PPV = positive predictive value
NPV = negative predictive value
Table 4: Diagnostic performance of the 4DSQ distress scale and 
the HADS total score with respect to detecting any depressive 
or anxiety disorder (prevalence 61%)* (Continued)BMC Family Practice 2009, 10:58 http://www.biomedcentral.com/1471-2296/10/58
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Limitations and strengths
Our study sample was limited by the selection of dis-
tressed general practice patients (considered to have a
'nervous breakdown'), aged 18–60 years, being
employed, and being on sick leave. Therefore, some cau-
tion should be observed in generalizing our results to dis-
tressed older patients (>60 years), distressed patients
without paid employment, and employed distressed
patients who are not on sick leave. Moreover, even more
caution should be observed in generalizing our results to
patients who do not disclose their distress to their GP.
Such patients, who nevertheless have a relatively high risk
for depressive and anxiety disorders, are, in particular,
patients with medically unexplained physical symptoms
[41] and patients with chronic somatic diseases [42].
Future research should clarify whether the results of the
present study can be generalized to these important
patient groups.
The GPs were instructed to exclude patients with obvious
(i.e. already diagnosed) depressive or anxiety disorders.
Recognizing that case mix differences may impact the per-
formance characteristics of diagnostic tests [39], let us
consider how our results could have looked like if we had
not excluded these patients. Patients with GP diagnosed
depressive and anxiety disorders would probably have
had more severe symptoms and disorders than those
included in the present study sample. Therefore, they
would have had a relatively high probability of fulfilling
the DSM-IV criteria for caseness (according to the CIDI
interview), and a smaller chance of obtaining false-nega-
tive test results than the present sub-sample of CIDI-DSM-
IV cases in the study sample. Addition of such a more
severe group of patients to our sample would, therefore,
have resulted in increased sensitivity values as relatively
more cases would have been correctly classified. In addi-
tion, because of the rise in prevalence, the positive predic-
tive values would have increased and the negative
predictive values would have decreased. Moreover, due to
an increase in contrast between cases and non-cases, the
diagnostic accuracy (AUC values) would probably have
increased, and due to a shift in the severity spectrum, the
optimal cut-off points would probably have shifted to
higher values. In other words, it is unlikely that the exclu-
sion of patients with obvious depressive and anxiety dis-
orders in our study has resulted in an overestimation of
the diagnostic accuracy of the questionnaires.
The exclusion of patients with obvious depressive and
anxiety disorders can also be considered to be a strength
of the study. Considering that a diagnostic instrument is
meant to be used in situations where there is a diagnostic
problem, diagnostic research should be performed in rel-
evant patient populations (the 'relevant domain') [40].
With respect to detecting depressive and anxiety disorders,
Table 5: Diagnostic performance of the 4DSQ and HADS 
depression scales with respect to detecting any major depressive 
disorder (prevalence 49%)*
4DSQ depression sensitivity specificity PPV NPV
≥1 0.96 0.34 0.59 0.89
≥20 . 8 8 0.46 0.62 0.80
≥3 0.78 0.60 0.66 0.74
≥4 0.65 0.72 0.69 0.68
≥5 0.53 0.79 0.71 0.63
≥6 0.45 0.83 0.71 0.60
≥7 0.32 0.87 0.71 0.57
≥8 0.25 0.92 0.75 0.56
≥9 0.18 0.93 0.72 0.54
≥10 0.12 0.97 0.78 0.53
HADS depression
≥7 0.97 0.30 0.57 0.92
≥8 0.93 0.39 0.60 0.84
≥90 . 8 8 0.49 0.63 0.81
≥10 0.84 0.60 0.68 0.80
≥11 0.75 0.67 0.69 0.73
≥12 0.60 0.75 0.70 0.65
≥13 0.49 0.78 0.69 0.61
≥14 0.40 0.88 0.77 0.60
≥15 0.32 0.89 0.73 0.57
≥16 0.21 0.93 0.74 0.55
≥17 0.16 0.96 0.79 0.54
* For each scale three cut-off points are highlighted in bold type: the 
optimal cut-off point with the best balance between sensitivity and 
specificity, the best lower cut-off point with a sensitivity ≥0.85, and 
the best higher cut-off point with a specificity ≥0.85
4DSQ = Four-Dimensional Symptom Questionnaire
HADS = Hospital Anxiety and Depression Scale
PPV = positive predictive value
NPV = negative predictive valueBMC Family Practice 2009, 10:58 http://www.biomedcentral.com/1471-2296/10/58
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Table 6: Diagnostic performance of the 4DSQ and HADS 
depression scales with respect to detecting moderate and severe 
major depressive disorder (prevalence 26%)*
4DSQ depression sensitivity specificity PPV NPV
≥2 0.96 0.38 0.36 0.97
≥30 . 8 7 0.52 0.39 0.92
≥4 0.78 0.65 0.45 0.89
≥5 0.64 0.73 0.46 0.85
≥6 0.59 0.79 0.51 0.84
≥7 0.46 0.87 0.55 0.82
≥8 0.39 0.91 0.61 0.81
≥9 0.27 0.93 0.58 0.78
≥10 0.21 0.97 0.70 0.77
HADS depression
≥8 0.96 0.30 0.33 0.96
≥9 0.91 0.38 0.35 0.92
≥10 0.87 0.48 0.37 0.91
≥11 0.81 0.56 0.40 0.89
≥12 0.64 0.65 0.40 0.84
≥13 0.56 0.72 0.42 0.82
≥14 0.49 0.82 0.49 0.82
≥15 0.39 0.85 0.48 0.79
≥16 0.27 0.90 0.50 0.77
≥17 0.22 0.95 0.59 0.77
* For each scale three cut-off points are highlighted in bold type: the 
optimal cut-off point with the best balance between sensitivity and 
specificity, the best lower cut-off point with a sensitivity ≥0.85, and 
the best higher cut-off point with a specificity ≥0.85
4DSQ = Four-Dimensional Symptom Questionnaire
HADS = Hospital Anxiety and Depression Scale
PPV = positive predictive value
NPV = negative predictive value
Table 7: Diagnostic performance of the 4DSQ and HADS anxiety 
scales with respect to detecting any anxiety disorder (prevalence 
34%)*
4DSQ anxiety sensitivity specificity PPV NPV
≥1 0.98 0.20 0.38 0.95
≥2 0.94 0.33 0.41 0.91
≥3 0.90 0.45 0.45 0.90
≥40 . 8 5 0.57 0.50 0.88
≥5 0.75 0.64 0.51 0.83
≥6 0.70 0.72 0.56 0.82
≥7 0.67 0.78 0.60 0.82
≥8 0.65 0.84 0.67 0.82
≥9 0.59 0.88 0.71 0.81
≥10 0.54 0.90 0.73 0.79
≥11 0.40 0.91 0.70 0.75
≥12 0.32 0.93 0.71 0.73
≥13 0.24 0.94 0.67 0.71
≥14 0.20 0.95 0.67 0.70
HADS anxiety
≥8 0.98 0.27 0.40 0.96
≥9 0.98 0.35 0.43 0.97
≥10 0.91 0.43 0.45 0.90
≥11 0.84 0.51 0.46 0.86
≥12 0.78 0.63 0.51 0.85
≥13 0.65 0.70 0.52 0.80
≥14 0.58 0.78 0.57 0.78
≥15 0.47 0.83 0.58 0.75
≥16 0.32 0.89 0.59 0.72
≥17 0.21 0.93 0.62 0.70
≥18 0.15 0.97 0.71 0.69
* For each scale three cut-off points are highlighted in bold type: the 
optimal cut-off point with the best balance between sensitivity and 
specificity, the best lower cut-off point with a sensitivity ≥0.85, and 
the best higher cut-off point with a specificity ≥0.85
4DSQ = Four-Dimensional Symptom Questionnaire
HADS = Hospital Anxiety and Depression Scale
PPV = positive predictive value
NPV = negative predictive valueBMC Family Practice 2009, 10:58 http://www.biomedcentral.com/1471-2296/10/58
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there is no diagnostic problem in patients in whom
depressive and anxiety disorders are clearly discernable.
When the patients' depressive and anxiety disorders are
obvious, the application of tools to detect these disorders
is superfluous. In the present study, we have selected a rel-
evant population of distressed patient, in whom depres-
sive and anxiety disorders often remain undetected as
such [6].
Further considerations
In our study, GPs were requested to recruit 'nervous break-
down' patients on sick leave, and to exclude patients with
readily diagnosable depressive and anxiety disorders.
Nevertheless, when the patients were subsequently sub-
jected to a standardized diagnostic interview (the CIDI),
one third of them (34%) received a diagnosis of moderate
or severe major depressive disorder and/or panic disorder,
agoraphobia or social phobia. As much as 61% of the
patients received any DSM-IV depressive or anxiety disor-
der diagnosis. Our results thus illustrate that, when
patients present themselves with a story of a 'nervous
breakdown', GPs tend to overlook depressive and anxiety
disorders, even those that are severe enough to justify a
specific diagnosis and treatment. Our concerns explicitly
regard the latter group, the 26% of the patients with a
moderate or severe major depressive disorder and the
19% of the patients with a panic disorder, agoraphobia or
social phobia (together 34% of the sample). We do not
worry about the patients with mild major depressive dis-
orders as they probably would not benefit from a specific
antidepressant treatment [43,44]. We do recognize that
these 'mild' patients need their distress to be recognized
and managed, but they do not need to be given a label of
'major depressive disorder'. We do not worry either about
patients with 'generalized anxiety disorder' as the essence
of this diagnosis is distress for a period of more than six
months. In a sample of distressed patients not all patients
with distress for more than six months are chronic worri-
ers; some or perhaps most of them are just confronted
with long-lasting social difficulties and stressors, and,
although we recognize that these patients need their dis-
tress to be recognized and taken care of, most of them are
unlikely to benefit from a diagnosis of 'anxiety disorder'.
In addition, there is one more argument in favour of
refraining from screening for just any depressive or anxi-
ety disorder (as opposed to more severe disorders only) in
a sample of relatively severely distressed patients (who
have gone on sick leave) in primary care. The argument is
that, in this particular case, screening is not very successful
in separating out patients with probabilities for caseness
small enough to justify no further investigation or follow-
up. We have seen that, in this sample with a prevalence of
61% for any depressive or anxiety disorder (49% for any
major depressive disorder and 34% for any anxiety disor-
Table 8: Diagnostic performance of the 4DSQ and HADS anxiety 
scales with respect to detecting panic disorder, agoraphobia and 
social phobia (prevalence 19%)*
4DSQ anxiety sensitivity specificity PPV NPV
≥4 0.98 0.53 0.33 0.99
≥5 0.89 0.61 0.35 0.96
≥60 . 8 6 0.68 0.39 0.95
≥7 0.82 0.73 0.42 0.95
≥8 0.79 0.78 0.46 0.94
≥9 0.71 0.82 0.49 0.92
≥10 0.64 0.85 0.49 0.91
≥11 0.54 0.89 0.53 0.89
≥12 0.43 0.91 0.53 0.87
≥13 0.32 0.93 0.50 0.85
≥14 0.27 0.94 0.50 0.85
≥15 0.23 0.96 0.56 0.84
HADS anxiety
≥8 1.00 0.23 0.23 1.00
≥9 1.00 0.29 0.25 1.00
≥10 0.95 0.38 0.26 0.97
≥11 0.86 0.45 0.27 0.93
≥12 0.80 0.56 0.30 0.92
≥13 0.68 0.65 0.31 0.90
≥14 0.63 0.73 0.35 0.89
≥15 0.57 0.80 0.40 0.89
≥16 0.41 0.87 0.43 0.86
≥17 0.27 0.92 0.44 0.84
≥18 0.20 0.96 0.52 0.84
* For each scale three cut-off points are highlighted in bold type: the 
optimal cut-off point with the best balance between sensitivity and 
specificity, the best lower cut-off point with a sensitivity ≥0.85, and 
the best higher cut-off point with a specificity ≥0.85
4DSQ = Four-Dimensional Symptom Questionnaire
HADS = Hospital Anxiety and Depression Scale
PPV = positive predictive value
NPV = negative predictive valueBMC Family Practice 2009, 10:58 http://www.biomedcentral.com/1471-2296/10/58
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der), it is difficult to exclude caseness because of relatively
low predictive values of negative scores (NPV; see Table
4). If, for some reason, one insists on diagnosing any
DSM-IV depressive or anxiety disorder, one virtually has
to investigate every patient in a situation where the prior
probability of being a case is as high as 61%. On the other
hand, if one is dealing with a sample comprising more
mildly, and perhaps less obviously distressed patients,
one might be interested in detecting any DSM-IV depres-
sive or anxiety disorder in order to find patients distressed
severely enough to warrant special attention (not specific
treatment), then the HADS (both the depression and anx-
iety scales, or the total scale) can be used for that purpose,
as well as the 4DSQ distress scale. The distress scale meas-
ures 'normal' everyday distress in the score range 0–10.
From the score of 11 upwards the distress scale measures
moderate to severe distress that is associated with (occu-
pational) stress, social dysfunctioning and sickness
absence [45,46]. Our findings suggest that in the score
range 11–20 there is distress with a relatively small prob-
ability of having any DSM-IV defined depressive or anxi-
ety disorder, while in the range 21–32 there is an
increasing probability for such a disorder.
Conclusion
In a sample of distressed general practice patients, the
4DSQ and the HADS are both able to detect any DSM-IV
depressive or anxiety disorder. However, when one is spe-
cifically interested in detecting cases severe enough to war-
rant specific treatment (e.g. antidepressant
pharmacotherapy or specialized cognitive behavioural
therapy), the 4DSQ has some advantage over the HADS,
especially for the detection of panic disorder, agoraphobia
and social phobia. Future research should focus on the
diagnostic accuracy in high-risk groups, in particular in
patients presenting their distress to their GP, patients with
medically unexplained physical symptoms and patients
with chronic physical conditions. Special attention needs
to be given to optimal cut-off points in these groups as
these may very well differ from those determined in unse-
lected primary care patients.
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